Toshifumi Sato
Niigata, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Impact of TOPAZ-1 eligibility on the survival benefit of durvalumab plus gemcitabine-cisplatin in advanced biliary tract cancer: a multicenter real-world study.
Journal: Journal of gastroenterology
Published: February 20, 2026
Survival Outcomes of Gemcitabine-Cisplatin-S-1 Versus Gemcitabine-Cisplatin in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Study With a Focus on Conversion Surgery.
Journal: Annals of gastroenterological surgery
Published: January 08, 2026
Effect of Partial Splenic Embolization on Immune Environment and Hepatic Function in Cirrhosis Patients With Portal Hypertension.
Journal: In vivo (Athens, Greece)
Published: October 24, 2025
Efficacy of Durvalumab-Tremelimumab Treatment in Combination With Locoregional Therapy in Unresectable Hepatocellular Carcinoma: A Preliminary Study.
Journal: Cancer diagnosis & prognosis
Published: July 01, 2025
Angiotensin Receptor Neprilysin Inhibitors for Hypertension and Proteinuria Management During Atezolizumab/Bevacizumab Treatment for Hepatocellular Carcinoma.
Journal: Cancer diagnosis & prognosis
Published: May 02, 2025
Transjugular Liver Biopsy for Histological Diagnosis of Refractory Ascites and Evaluation of Portal Hypertension.
Journal: In vivo (Athens, Greece)
Published: February 12, 2025
Acute Cholangitis Caused by Migration of a Pancreatic Stent Into a Biliary Stent.
Journal: Journal of hepato-biliary-pancreatic sciences
Published: January 25, 2025
Partial Splenic Embolization for Portal Hypertension Exacerbation During Atezolizumab/Bevacizumab Combination Therapy in Unresectable Hepatocellular Carcinoma.
Journal: In vivo (Athens, Greece)
Published: December 26, 2024
Effectiveness of Steerable Microcatheters During Transarterial Chemoembolization for Hepatocellular Carcinoma.
Journal: Cancer diagnosis & prognosis
Published: September 12, 2024
Suppression of popping rates in radiofrequency ablation under perfluorobutane microbubbles for hepatocellular carcinoma.
Journal: Clinical and experimental hepatology
Published: May 26, 2024
Comparison of Local Recurrence Between LEN-TACE and TACE for Hepatocellular Carcinoma According to Lipiodol Accumulation.
Journal: Cancer diagnosis & prognosis
Published: May 02, 2024
Last Updated: 09/26/2026